Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novavax reported $871K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Adma Biologics ADMA:US USD 22K 0
Agenus AGEN:US USD 3.42M 361K
AstraZeneca AZN:LN USD 387M 0
Dynavax Technologies DVAX:US USD 128K 0
Geron GERN:US USD 509K 119K
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
MannKind MNKD:US USD 2.64M 5K
Minerva Neurosciences NERV:US USD 1000 0
Moderna Inc MRNA:US USD 38.4K 100
Novartis NVS:US USD 842M 48M
Novavax NVAX:US USD 871K 3K
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Sarepta Therapeutics SRPT:US USD 9K 0
TG Therapeutics TGTX:US USD 149K 3K